Skip to main content
Erschienen in: Inflammation 1/2023

02.08.2022 | Original Article

Circ_0088194 Regulates Proliferation, Migration, Apoptosis, and Inflammation by miR-30a-3p/ADAM10 Axis in Rheumatoid Arthritis Fibroblastic Synovial Cells

verfasst von: Lei Feng, Wenseng Jing, Shengyu Jin, Bo Wang

Erschienen in: Inflammation | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Dysregulation of circular RNAs (circRNAs) has been observed in multiple diseases including rheumatoid arthritis (RA), and we investigated the role of the circ_0088194/microRNA (miR)-30a-3p/a disintegrin and metalloproteinase 10 (ADAM10) axis in RA. Circ_0088194, miR-30a-3p, and ADAM10 contents in RA tissues and RA-fibroblast-like synoviocytes (RA-FLSs) were analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) and western blot. Cell proliferation, migration, apoptosis, and inflammatory factor secretion of RA-FLSs were detected using 5-ethynyl-2’-deoxyuridine (EdU), wound healing assay, flow cytometry, and enzyme-linked immunosorbent assay (ELISA). Targeting relationship between miR-30a-3p and circ_0088194 or ADAM10 was validated by luciferase reporter system, RNA immunoprecipitation (RIP), and RNA pull-down assays. Circ_0088194 and ADAM10 levels were increased, while miR-30a-3p was decreased in RA tissues and RA-FLSs. Circ_0088194 knockdown suppressed the growth, migration, and inflammation of RA-FLSs, while the upregulation of circ_0088194 showed opposite effects. Circ_0088194 directly targeted miR-30a-3p, ADAM10 was a target of miR-30a-3p, and circ_0088194 regulated the expression of ADAM10 by sponging miR-30a-3p. MiR-30a-3p inhibition restored the inhibition effects of circ_0088194 knockdown or RA-FLSs. Moreover, miR-30a-3p re-expression repressed growth, migration, and inflammatory response in RA-FLSs, which were reversed by ADAM10 overexpression. Circ_0088194 acted on miR-30a-3p/ADAM10 axis to promote the proliferation, migration, and inflammatory response, and inhibit apoptosis in RA-FLSs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Giannini, D., M. Antonucci, F. Petrelli, S. Bilia, A. Alunno, and I. Puxeddu. 2020. One year in review 2020: Pathogenesis of rheumatoid arthritis. Clinical and Experimental Rheumatology 38 (3): 387–397.PubMed Giannini, D., M. Antonucci, F. Petrelli, S. Bilia, A. Alunno, and I. Puxeddu. 2020. One year in review 2020: Pathogenesis of rheumatoid arthritis. Clinical and Experimental Rheumatology 38 (3): 387–397.PubMed
2.
Zurück zum Zitat Lin, Y.J., M. Anzaghe, and S. Schülke. 2020. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9 (4). Lin, Y.J., M. Anzaghe, and S. Schülke. 2020. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9 (4).
3.
Zurück zum Zitat Rheumatoid arthritis. 2018. Nature Reviews Disease Primers 4:18002. Rheumatoid arthritis. 2018. Nature Reviews Disease Primers 4:18002.
4.
Zurück zum Zitat Littlejohn, E.A., and S.U. Monrad. 2018. Early diagnosis and treatment of rheumatoid arthritis. Primary Care 45 (2): 237–255.CrossRefPubMed Littlejohn, E.A., and S.U. Monrad. 2018. Early diagnosis and treatment of rheumatoid arthritis. Primary Care 45 (2): 237–255.CrossRefPubMed
5.
Zurück zum Zitat Wu, Z., D. Ma, H. Yang, J. Gao, G. Zhang, K. Xu, and L. Zhang. 2021. Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes. International immunopharmacology 93: 107392.CrossRefPubMed Wu, Z., D. Ma, H. Yang, J. Gao, G. Zhang, K. Xu, and L. Zhang. 2021. Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes. International immunopharmacology 93: 107392.CrossRefPubMed
6.
Zurück zum Zitat Nygaard, G., and G.S. Firestein. 2020. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nature reviews Rheumatology 16 (6): 316–333.CrossRefPubMedPubMedCentral Nygaard, G., and G.S. Firestein. 2020. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nature reviews Rheumatology 16 (6): 316–333.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Filer, A. 2013. The fibroblast as a therapeutic target in rheumatoid arthritis. Current opinion in pharmacology 13 (3): 413–419.CrossRefPubMed Filer, A. 2013. The fibroblast as a therapeutic target in rheumatoid arthritis. Current opinion in pharmacology 13 (3): 413–419.CrossRefPubMed
8.
Zurück zum Zitat Gao, J.L., G. Chen, H.Q. He, and J. Wang. 2018. CircRNA as a new field in human disease research. Zhongguo Zhong Yao Za Zhi 43 (3): 457–462.PubMed Gao, J.L., G. Chen, H.Q. He, and J. Wang. 2018. CircRNA as a new field in human disease research. Zhongguo Zhong Yao Za Zhi 43 (3): 457–462.PubMed
9.
Zurück zum Zitat Zhou, W.Y., Z.R. Cai, J. Liu, D.S. Wang, H.Q. Ju, and R.H. Xu. 2020. Circular RNA: Metabolism, functions and interactions with proteins. Molecular Cancer 19 (1): 172.CrossRefPubMedPubMedCentral Zhou, W.Y., Z.R. Cai, J. Liu, D.S. Wang, H.Q. Ju, and R.H. Xu. 2020. Circular RNA: Metabolism, functions and interactions with proteins. Molecular Cancer 19 (1): 172.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Yu, X.P., C.G. Liu, F. Qiu, Y.Q. Xu, F. Xing, J.Q. Yin, S.J. Han, H. Yu, Y. Han, X. Jing, et al. 2020. CircRNA_100395 protects breast carcinoma deterioration by targeting MAPK6. European Review for Medical and Pharmacological Sciences 24 (23): 12216–12223.PubMed Yu, X.P., C.G. Liu, F. Qiu, Y.Q. Xu, F. Xing, J.Q. Yin, S.J. Han, H. Yu, Y. Han, X. Jing, et al. 2020. CircRNA_100395 protects breast carcinoma deterioration by targeting MAPK6. European Review for Medical and Pharmacological Sciences 24 (23): 12216–12223.PubMed
11.
Zurück zum Zitat Li, H., J.D. Xu, X.H. Fang, J.N. Zhu, J. Yang, R. Pan, S.J. Yuan, N. Zeng, Z.Z. Yang, H. Yang, et al. 2020. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovascular Research 116 (7): 1323–1334.CrossRefPubMed Li, H., J.D. Xu, X.H. Fang, J.N. Zhu, J. Yang, R. Pan, S.J. Yuan, N. Zeng, Z.Z. Yang, H. Yang, et al. 2020. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovascular Research 116 (7): 1323–1334.CrossRefPubMed
12.
Zurück zum Zitat Luo, Q., J. Liu, B. Fu, L. Zhang, Y. Guo, Z. Huang, and J. Li. 2019. Circular RNAs Hsa_circ_0002715 and Hsa_circ_0035197 in peripheral blood are novel potential biomarkers for new-onset rheumatoid arthritis. Disease Markers 2019: 2073139.CrossRefPubMedPubMedCentral Luo, Q., J. Liu, B. Fu, L. Zhang, Y. Guo, Z. Huang, and J. Li. 2019. Circular RNAs Hsa_circ_0002715 and Hsa_circ_0035197 in peripheral blood are novel potential biomarkers for new-onset rheumatoid arthritis. Disease Markers 2019: 2073139.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yang, J., M. Cheng, B. Gu, J. Wang, S. Yan, and D. Xu. 2020. CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis. Cell death & disease 11 (10): 833.CrossRef Yang, J., M. Cheng, B. Gu, J. Wang, S. Yan, and D. Xu. 2020. CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis. Cell death & disease 11 (10): 833.CrossRef
14.
Zurück zum Zitat Chen, S., Z. Luo, and X. Chen. 2021. Hsa_circ_0044235 regulates the pyroptosis of rheumatoid arthritis via MiR-135b-5p-SIRT1 axis. Cell cycle (Georgetown, Tex) 20 (12): 1107–1121.CrossRefPubMed Chen, S., Z. Luo, and X. Chen. 2021. Hsa_circ_0044235 regulates the pyroptosis of rheumatoid arthritis via MiR-135b-5p-SIRT1 axis. Cell cycle (Georgetown, Tex) 20 (12): 1107–1121.CrossRefPubMed
15.
Zurück zum Zitat Cai, Y., R. Liang, S. Xiao, Q. Huang, D. Zhu, G.P. Shi, Q. Ouyang, and M. Yang. 2021. Circ_0088194 promotes the invasion and migration of rheumatoid arthritis fibroblast-like synoviocytes via the miR-766-3p/MMP2 Axis. Frontiers in Immunology 12: 628654.CrossRefPubMedPubMedCentral Cai, Y., R. Liang, S. Xiao, Q. Huang, D. Zhu, G.P. Shi, Q. Ouyang, and M. Yang. 2021. Circ_0088194 promotes the invasion and migration of rheumatoid arthritis fibroblast-like synoviocytes via the miR-766-3p/MMP2 Axis. Frontiers in Immunology 12: 628654.CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Vishnoi, A., and S. Rani. 2017. MiRNA biogenesis and regulation of diseases: An overview. Methods in molecular biology (Clifton, NJ) 1509: 1–10.CrossRef Vishnoi, A., and S. Rani. 2017. MiRNA biogenesis and regulation of diseases: An overview. Methods in molecular biology (Clifton, NJ) 1509: 1–10.CrossRef
18.
Zurück zum Zitat Cao, T., and X.C. Zhen. 2018. Dysregulation of miRNA and its potential therapeutic application in schizophrenia. CNS Neuroscience & Therapeutics 24 (7): 586–597.CrossRef Cao, T., and X.C. Zhen. 2018. Dysregulation of miRNA and its potential therapeutic application in schizophrenia. CNS Neuroscience & Therapeutics 24 (7): 586–597.CrossRef
19.
Zurück zum Zitat Ganju, A., S. Khan, B.B. Hafeez, S.W. Behrman, M.M. Yallapu, S.C. Chauhan, and M. Jaggi. 2017. miRNA nanotherapeutics for cancer. Drug Discovery Today 22 (2): 424–432.CrossRefPubMed Ganju, A., S. Khan, B.B. Hafeez, S.W. Behrman, M.M. Yallapu, S.C. Chauhan, and M. Jaggi. 2017. miRNA nanotherapeutics for cancer. Drug Discovery Today 22 (2): 424–432.CrossRefPubMed
20.
Zurück zum Zitat Chen, L., Q. Lu, J. Chen, R. Feng, and C. Yang. 2021. Upregulating miR-27a-3p inhibits cell proliferation and inflammation of rheumatoid arthritis synovial fibroblasts through targeting toll-like receptor 5. Experimental and Therapeutic Medicine 22 (5): 1227.CrossRefPubMedPubMedCentral Chen, L., Q. Lu, J. Chen, R. Feng, and C. Yang. 2021. Upregulating miR-27a-3p inhibits cell proliferation and inflammation of rheumatoid arthritis synovial fibroblasts through targeting toll-like receptor 5. Experimental and Therapeutic Medicine 22 (5): 1227.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Evangelatos, G., G.E. Fragoulis, V. Koulouri, and G.I. Lambrou. 2019. MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmunity Reviews 18 (11): 102391.CrossRefPubMed Evangelatos, G., G.E. Fragoulis, V. Koulouri, and G.I. Lambrou. 2019. MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmunity Reviews 18 (11): 102391.CrossRefPubMed
22.
Zurück zum Zitat Luo, Z., S. Chen, and X. Chen. 2021. CircMAPK9 promotes the progression of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-140-3p/PPM1A axis. Journal of Orthopaedic Surgery and Research 16 (1): 395.CrossRefPubMedPubMedCentral Luo, Z., S. Chen, and X. Chen. 2021. CircMAPK9 promotes the progression of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-140-3p/PPM1A axis. Journal of Orthopaedic Surgery and Research 16 (1): 395.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Alsaleh, G., A. François, L. Philippe, Y.Z. Gong, S. Bahram, S. Cetin, S. Pfeffer, J.E. Gottenberg, D. Wachsmann, P. Georgel, et al. 2014. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS ONE 9 (10): e111266.CrossRefPubMedPubMedCentral Alsaleh, G., A. François, L. Philippe, Y.Z. Gong, S. Bahram, S. Cetin, S. Pfeffer, J.E. Gottenberg, D. Wachsmann, P. Georgel, et al. 2014. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS ONE 9 (10): e111266.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Lv, X., J. Huang, and H. Wang. 2021. MiR-30a-3p ameliorates oxidative stress in rheumatoid arthritis synovial fibroblasts via activation of Nrf2-ARE signaling pathway. Immunology letters 232: 1–8.CrossRefPubMed Lv, X., J. Huang, and H. Wang. 2021. MiR-30a-3p ameliorates oxidative stress in rheumatoid arthritis synovial fibroblasts via activation of Nrf2-ARE signaling pathway. Immunology letters 232: 1–8.CrossRefPubMed
26.
Zurück zum Zitat Crawford, H.C., P.J. Dempsey, G. Brown, L. Adam, and M.L. Moss. 2009. ADAM10 as a therapeutic target for cancer and inflammation. Current Pharmaceutical Design 15 (20): 2288–2299.CrossRefPubMed Crawford, H.C., P.J. Dempsey, G. Brown, L. Adam, and M.L. Moss. 2009. ADAM10 as a therapeutic target for cancer and inflammation. Current Pharmaceutical Design 15 (20): 2288–2299.CrossRefPubMed
27.
Zurück zum Zitat Gibb, D.R., S.J. Saleem, N.S. Chaimowitz, J. Mathews, and D.H. Conrad. 2011. The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity. Molecular Immunology 48 (11): 1319–1327.CrossRefPubMedPubMedCentral Gibb, D.R., S.J. Saleem, N.S. Chaimowitz, J. Mathews, and D.H. Conrad. 2011. The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity. Molecular Immunology 48 (11): 1319–1327.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Guo, J., J. Du, D. Fei, J. Xing, J. Liu, and H. Lu. 2018. miR-152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10. International Journal of Molecular Medicine 42 (1): 643–650.PubMed Guo, J., J. Du, D. Fei, J. Xing, J. Liu, and H. Lu. 2018. miR-152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10. International Journal of Molecular Medicine 42 (1): 643–650.PubMed
29.
Zurück zum Zitat Aletaha, D., and J.S. Smolen. 2018. Diagnosis and management of rheumatoid arthritis: A review. Journal of the American Medical Association 320 (13): 1360–1372.CrossRefPubMed Aletaha, D., and J.S. Smolen. 2018. Diagnosis and management of rheumatoid arthritis: A review. Journal of the American Medical Association 320 (13): 1360–1372.CrossRefPubMed
30.
Zurück zum Zitat Burmester, G.R., and J.E. Pope. 2017. Novel treatment strategies in rheumatoid arthritis. Lancet 389 (10086): 2338–2348.CrossRefPubMed Burmester, G.R., and J.E. Pope. 2017. Novel treatment strategies in rheumatoid arthritis. Lancet 389 (10086): 2338–2348.CrossRefPubMed
31.
Zurück zum Zitat Zhou, Z., B. Sun, S. Huang, and L. Zhao. 2019. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell death & disease 10 (7): 503.CrossRef Zhou, Z., B. Sun, S. Huang, and L. Zhao. 2019. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell death & disease 10 (7): 503.CrossRef
32.
Zurück zum Zitat Lodde, V., G. Murgia, E.R. Simula, M. Steri, M. Floris, and M.L. Idda. 2020. Long noncoding RNAs and circular RNAs in Autoimmune diseases. Biomolecules 10 (7). Lodde, V., G. Murgia, E.R. Simula, M. Steri, M. Floris, and M.L. Idda. 2020. Long noncoding RNAs and circular RNAs in Autoimmune diseases. Biomolecules 10 (7).
33.
Zurück zum Zitat Li, X., B. Wang, M. Huang, and X. Wang. 2020. miR-30a-3p participates in the development of asthma by targeting CCR3. Open Med (Wars) 15 (1): 483–491.CrossRefPubMed Li, X., B. Wang, M. Huang, and X. Wang. 2020. miR-30a-3p participates in the development of asthma by targeting CCR3. Open Med (Wars) 15 (1): 483–491.CrossRefPubMed
34.
Zurück zum Zitat Wang, H., D. Kanmangne, R. Li, Z. Qian, X. Xia, X. Wang, and T. Wang. 2020. miR-30a-3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncology Reports 43 (2): 646–654.PubMed Wang, H., D. Kanmangne, R. Li, Z. Qian, X. Xia, X. Wang, and T. Wang. 2020. miR-30a-3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncology Reports 43 (2): 646–654.PubMed
35.
Zurück zum Zitat Ding, H., Y. Wang, L. Hu, S. Xue, Y. Wang, L. Zhang, Y. Zhang, H. Qi, H. Yu, L.H.H Aung, et al. 2020. Combined detection of miR-21–5p, miR-30a-3p, miR-30a-5p, miR-155–5p, miR-216a and miR-217 for screening of early heart failure diseases. Bioscience Reports 40 (3). Ding, H., Y. Wang, L. Hu, S. Xue, Y. Wang, L. Zhang, Y. Zhang, H. Qi, H. Yu, L.H.H Aung, et al. 2020. Combined detection of miR-21–5p, miR-30a-3p, miR-30a-5p, miR-155–5p, miR-216a and miR-217 for screening of early heart failure diseases. Bioscience Reports 40 (3).
36.
Zurück zum Zitat Rossello, A., A. Steinle, A. Poggi, and M.R. Zocchi. 2020. Editorial: ADAM10 in cancer immunology and autoimmunity: More than a simple biochemical scissor. Frontiers in Immunology 11: 1483.CrossRefPubMedPubMedCentral Rossello, A., A. Steinle, A. Poggi, and M.R. Zocchi. 2020. Editorial: ADAM10 in cancer immunology and autoimmunity: More than a simple biochemical scissor. Frontiers in Immunology 11: 1483.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Peron, R., I.P. Vatanabe, P.R. Manzine, A. Camins, and M.R. Cominetti. 2018. Alpha-secretase ADAM10 regulation: insights into Alzheimer's disease treatment. Pharmaceuticals (Basel) 11 (1). Peron, R., I.P. Vatanabe, P.R. Manzine, A. Camins, and M.R. Cominetti. 2018. Alpha-secretase ADAM10 regulation: insights into Alzheimer's disease treatment. Pharmaceuticals (Basel) 11 (1).
38.
Zurück zum Zitat Hong, Y.G., C. Xin, H. Zheng, Z.P. Huang, Y. Yang, J.D. Zhou, X.H. Gao, L. Hao, Q.Z. Liu, W. Zhang, et al. 2020. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells. Journal of Cancer 11 (12): 3634–3644.CrossRefPubMedPubMedCentral Hong, Y.G., C. Xin, H. Zheng, Z.P. Huang, Y. Yang, J.D. Zhou, X.H. Gao, L. Hao, Q.Z. Liu, W. Zhang, et al. 2020. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells. Journal of Cancer 11 (12): 3634–3644.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Isozaki, T., B.J. Rabquer, J.H. Ruth, G.K. Haines 3rd., and A.E. Koch. 2013. ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis. Arthritis and rheumatism 65 (1): 98–108.CrossRefPubMed Isozaki, T., B.J. Rabquer, J.H. Ruth, G.K. Haines 3rd., and A.E. Koch. 2013. ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis. Arthritis and rheumatism 65 (1): 98–108.CrossRefPubMed
40.
Zurück zum Zitat Xie, Z., P. Shen, Y. Qu, J. Xu, C. Zheng, Y. Gao, and B. Wang. 2020. MiR-20a inhibits the progression of human arthritis fibroblast-like synoviocytes and inflammatory factor expression by targeting ADAM10. Environmental toxicology 35 (8): 867–878.CrossRefPubMed Xie, Z., P. Shen, Y. Qu, J. Xu, C. Zheng, Y. Gao, and B. Wang. 2020. MiR-20a inhibits the progression of human arthritis fibroblast-like synoviocytes and inflammatory factor expression by targeting ADAM10. Environmental toxicology 35 (8): 867–878.CrossRefPubMed
Metadaten
Titel
Circ_0088194 Regulates Proliferation, Migration, Apoptosis, and Inflammation by miR-30a-3p/ADAM10 Axis in Rheumatoid Arthritis Fibroblastic Synovial Cells
verfasst von
Lei Feng
Wenseng Jing
Shengyu Jin
Bo Wang
Publikationsdatum
02.08.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01719-9

Weitere Artikel der Ausgabe 1/2023

Inflammation 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.